The Effects of Peroxisome Proliferator-Activated Receptor-Delta Modulator ASP1128 in Patients at Risk for Acute Kidney Injury Following Cardiac Surgery
Open Access
- 8 April 2023
- journal article
- research article
- Published by Elsevier in Kidney International Reports
- Vol. 8 (7) , 1407-1416
Abstract
No abstract availableKeywords
Funding Information
- Astellas Pharma US
- Astellas Pharma
This publication has 26 references indexed in Scilit:
- Meclizine Preconditioning Protects the Kidney Against Ischemia–Reperfusion InjuryEBioMedicine, 2015
- Urinary TIMP-2 and IGFBP7 as Early Biomarkers of Acute Kidney Injury and Renal Recovery following Cardiac SurgeryPLOS ONE, 2014
- New peroxisome proliferator-activated receptor agonists: potential treatments for atherogenic dyslipidemia and non-alcoholic fatty liver diseaseExpert Opinion on Pharmacotherapy, 2014
- PPARδ activation in human myotubes increases mitochondrial fatty acid oxidative capacity and reduces glucose utilization by a switch in substrate preferenceArchives of Physiology and Biochemistry, 2013
- Discovery and validation of cell cycle arrest biomarkers in human acute kidney injuryCritical Care, 2013
- Acute kidney injuryThe Lancet, 2012
- Cellular pathophysiology of ischemic acute kidney injuryJournal of Clinical Investigation, 2011
- Glucose metabolism inhibits apoptosis in neurons and cancer cells by redox inactivation of cytochrome cNature Cell Biology, 2008
- Direct multiplexed measurement of gene expression with color-coded probe pairsNature Biotechnology, 2008
- Hypoxia Tolerance in Mammals and Birds: From the Wilderness to the ClinicAnnual Review of Physiology, 2007